Log in

Relevant bibliographies by topics / Amyloid beta-protein precursor / Journal articles

To see the other types of publications on this topic, follow the link: Amyloid beta-protein precursor.

Journal articles on the topic 'Amyloid beta-protein precursor'

Author: Grafiati

Published: 4 June 2021

Last updated: 26 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Amyloid beta-protein precursor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Koo, E. H., S. L. Squazzo, D. J. Selkoe, and C. H. Koo. "Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody." Journal of Cell Science 109, no. 5 (May 1, 1996): 991–98. http://dx.doi.org/10.1242/jcs.109.5.991.

Full text

Abstract:

Amyloid beta-protein, the principal constituent of amyloid fibrils found in senile plaques and blood vessels in Alzheimer's disease, is constitutively produced and released into medium of cultured cells. Amyloid beta-protein is derived by proteolysis of the beta-amyloid precursor protein by unclear mechanisms. Beta-amyloid precursor protein is a transmembrane protein which can be processed to release a large secretory product or processed in the endosomal/lysosomal pathway without secretion. Previous studies have shown that from the cell surface, beta-amyloid precursor protein may be released

APA, Harvard, Vancouver, ISO, and other styles

2

Naushad, Mehjabeen, Siva Sundara Kumar Durairajan, Amal Kanti Bera, Sanjib Senapati та Min Li. "Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimerʼs Disease". Planta Medica 85, № 17 (16 жовтня 2019): 1316–25. http://dx.doi.org/10.1055/a-1019-9819.

Full text

Abstract:

AbstractAlzheimerʼs disease is a neurodegenerative disease that leads to irreversible neuronal damage. Senile plaques, composed of amyloid beta peptide, is the principal abnormal characteristic of the disease. Among the factors involved, the secretase enzymes, namely, α secretase, beta-site amyloid precursor protein-cleaving enzyme, β secretase, and γ secretase, hold consequential importance. Beta-site amyloid precursor protein-cleaving enzyme 1 is considered to be the rate-limiting factor in the production of amyloid beta peptide. Research supporting the concept of inhibition of beta-site amy

APA, Harvard, Vancouver, ISO, and other styles

3

Cai, X., T. Golde, and S. Younkin. "Release of excess amyloid beta protein from a mutant amyloid beta protein precursor." Science 259, no. 5094 (January 22, 1993): 514–16. http://dx.doi.org/10.1126/science.8424174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Nunan, Janelle, and David H. Small. "Proteolytic processing of the amyloid-beta protein precursor of Alzheimer's disease." Essays in Biochemistry 38 (October 1, 2002): 37–49. http://dx.doi.org/10.1042/bse0380037.

Full text

Abstract:

The proteolytic processing of the amyloid-beta protein precursor plays a key role in the development of Alzheimer's disease. Cleavage of the amyloid-beta protein precursor may occur via two pathways, both of which involve the action of proteases called secretases. One pathway, involving beta- and gamma-secretase, liberates amyloid-beta protein, a protein associated with the neurodegeneration seen in Alzheimer's disease. The alternative pathway, involving alpha-secretase, precludes amyloid-beta protein formation. In this review, we describe the progress that has been made in identifying the sec

APA, Harvard, Vancouver, ISO, and other styles

5

Parkin, Edward T., Jessica E. Hammond, Lauren Owens, and Matthew D. Hodges. "The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein." PLOS ONE 17, no. 1 (January 13, 2022): e0255715. http://dx.doi.org/10.1371/journal.pone.0255715.

Full text

Abstract:

The amyloid cascade hypothesis proposes that excessive accumulation of amyloid beta-peptides is the initiating event in Alzheimer’s disease. These neurotoxic peptides are generated from the amyloid precursor protein via sequential cleavage by β- and γ-secretases in the ’amyloidogenic’ proteolytic pathway. Alternatively, the amyloid precursor protein can be processed via the ’non-amyloidogenic’ pathway which, through the action of the α-secretase a disintegrin and metalloproteinase (ADAM) 10, both precludes amyloid beta-peptide formation and has the additional benefit of generating a neuroprote

APA, Harvard, Vancouver, ISO, and other styles

6

Wilquet, Valérie, and Bart De Strooper. "Amyloid-beta precursor protein processing in neurodegeneration." Current Opinion in Neurobiology 14, no. 5 (October 2004): 582–88. http://dx.doi.org/10.1016/j.conb.2004.08.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Schubert, David, Greg Cole, Tsunao Saitoh, and Tilman Oltersdorf. "Amyloid beta protein precursor is a mitogen." Biochemical and Biophysical Research Communications 162, no. 1 (July 1989): 83–88. http://dx.doi.org/10.1016/0006-291x(89)91965-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ling, Xie, R. N. Martins, M. Racchi, S. Craft, and E. Helmerhorst. "Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor." Journal of Alzheimer's Disease 4, no. 5 (November 1, 2002): 369–74. http://dx.doi.org/10.3233/jad-2002-4504.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ayoubi, Riham, Maryam Fotouhi, Donovan Worrall, Kathleen Southern, and Carl Laflamme. "Identification of high-performing antibodies for amyloid-beta precursor protein for use in Western Blot, immunoprecipitation and immunofluorescence." F1000Research 12 (August 9, 2023): 956. http://dx.doi.org/10.12688/f1000research.139867.1.

Full text

Abstract:

The amyloid-beta precursor protein is a transmembrane protein expressed in many tissues and highly concentrated in the brain. The protein is of significant interest due to its involvement in the generation of amyloidogenic β-amyloid peptides, prone to plaque formation that is characteristic of Alzheimer’s Disease. The scientific community would benefit from the availability of high-quality anti-amyloid-beta precursor protein antibodies to enhance reproducible research on this target. In this study, we characterized eleven amyloid-beta precursor protein commercial antibodies for Western blot, i

APA, Harvard, Vancouver, ISO, and other styles

10

Ghiso, J., E. Matsubara, A. Koudinov, N. H. Choi-Miura, M. Tomita, T. Wisniewski та B. Frangione. "The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex". Biochemical Journal 293, № 1 (1 липня 1993): 27–30. http://dx.doi.org/10.1042/bj2930027.

Full text

Abstract:

The amyloid fibrils deposited in Alzheimer's neuritic plaque cores and cerebral blood vessels are mainly composed of aggregated forms of a unique peptide, 39-42 amino acids long, named amyloid beta (A beta). A similar, although soluble, A beta (‘sA beta’) has been identified in cerebrospinal fluid, plasma and cell supernatants, indicating that it is normally produced by proteolytic processing of its precursor protein, amyloid precursor protein (APP). Using direct binding experiments we have isolated and characterized an 80 kDa circulating protein that specifically interacts with a synthetic pe

APA, Harvard, Vancouver, ISO, and other styles

11

Suzuki, N., T. Cheung, X. Cai, A. Odaka, L. Otvos, C. Eckman, T. Golde, and S. Younkin. "An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants." Science 264, no. 5163 (May 27, 1994): 1336–40. http://dx.doi.org/10.1126/science.8191290.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Ayoubi, Riham, Maryam Fotouhi, Donovan Worrall, Kathleen Southern, and Carl Laflamme. "A guide to selecting high-performing antibodies for amyloid-beta precursor protein for use in Western Blot, immunoprecipitation and immunofluorescence." F1000Research 12 (April 10, 2024): 956. http://dx.doi.org/10.12688/f1000research.139867.2.

Full text

Abstract:

The amyloid-beta precursor protein is a transmembrane protein expressed in many tissues and highly concentrated in the brain. The protein is of significant interest due to its involvement in the generation of amyloidogenic β-amyloid peptides, prone to plaque formation that is characteristic of Alzheimer’s Disease. The scientific community would benefit from the availability of high-quality anti-amyloid-beta precursor protein antibodies to enhance reproducible research on this target. In this study, we characterized eleven amyloid-beta precursor protein commercial antibodies for Western blot, i

APA, Harvard, Vancouver, ISO, and other styles

13

Younkin, S. G., X. H. Song, D. Scheuner, C. Eckman, C.-M. Prada, J. Jensen, L. Lannfelt, et al. "The effect of amyloid precursor protein and presenilin mutations on amyloid beta protein." Biological Psychiatry 39, no. 7 (April 1996): 562. http://dx.doi.org/10.1016/0006-3223(96)84161-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Ambure, Pravin, та Kunal Roy. "Understanding the structural requirements of cyclic sulfone hydroxyethylamines as hBACE1 inhibitors against Aβ plaques in Alzheimer's disease: a predictive QSAR approach". RSC Advances 6, № 34 (2016): 28171–86. http://dx.doi.org/10.1039/c6ra04104c.

Full text

Abstract:

Beta (β)-site amyloid precursor protein cleaving enzyme 1 (BACE1) is one of the most important targets in Alzheimer's disease (AD), which is responsible for production and accumulation of beta amyloid (Aβ).

APA, Harvard, Vancouver, ISO, and other styles

15

Haass, C., E. H. Koo, D. B. Teplow, and D. J. Selkoe. "Polarized secretion of beta-amyloid precursor protein and amyloid beta-peptide in MDCK cells." Proceedings of the National Academy of Sciences 91, no. 4 (February 15, 1994): 1564–68. http://dx.doi.org/10.1073/pnas.91.4.1564.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Jin, Lee-Way, та Hyun-seok Hong. "P1-450: Tomoregulin-2 binds beta-amyloid precursor protein and intracellular beta-amyloid (Aβ)". Alzheimer's & Dementia 4 (липень 2008): T351—T352. http://dx.doi.org/10.1016/j.jalz.2008.05.1032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Mattson, M. P. "Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives." Physiological Reviews 77, no. 4 (October 1, 1997): 1081–132. http://dx.doi.org/10.1152/physrev.1997.77.4.1081.

Full text

Abstract:

beta-Amyloid precursor protein (beta-APP), the source of the fibrillogenic amyloid beta-peptide (A beta) that accumulates in the brain of victims of Alzheimer's disease, is a multifunctional protein that is widely expressed in the nervous system. beta-Amyloid precursor protein is axonally transported and accumulates in presynaptic terminals and growth cones. A secreted form of beta-APP (sAPP alpha) is released from neurons in response to electrical activity and may function in modulation of neuronal excitability, synaptic plasticity, neurite outgrowth, synaptogenesis, and cell survival. A sign

APA, Harvard, Vancouver, ISO, and other styles

18

Mönning, U., G. König, R. B. Banati, H. Mechler, C. Czech, J. Gehrmann, U. Schreiter-Gasser, C. L. Masters, and K. Beyreuther. "Alzheimer beta A4-amyloid protein precursor in immunocompetent cells." Journal of Biological Chemistry 267, no. 33 (November 1992): 23950–56. http://dx.doi.org/10.1016/s0021-9258(18)35929-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Jaffe, A. B., C. D. Toran-Allerand, P. Greengard, and S. E. Gandy. "Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein." Journal of Biological Chemistry 269, no. 18 (May 1994): 13065–68. http://dx.doi.org/10.1016/s0021-9258(17)36796-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Schmaier, Alvin H. "The amyloid beta-precursor protein—The unappreciated cerebral anticoagulant." Thrombosis Research 155 (July 2017): 149–51. http://dx.doi.org/10.1016/j.thromres.2017.05.037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Donnelly, Robert J., Arnold J. Friedhoff, Bernard Beer, Arthur J. Blume, and Michael P. Vitek. "Interleukin-1 stimulates the beta-amyloid precursor protein promoter." Cellular and Molecular Neurobiology 10, no. 4 (December 1990): 485–95. http://dx.doi.org/10.1007/bf00712843.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Orobets, Kseniia S., and Andrey L. Karamyshev. "Amyloid Precursor Protein and Alzheimer’s Disease." International Journal of Molecular Sciences 24, no. 19 (September 30, 2023): 14794. http://dx.doi.org/10.3390/ijms241914794.

Full text

Abstract:

Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders associated with age or inherited mutations. It is characterized by severe dementia in the late stages that affect memory, cognitive functions, and daily life overall. AD progression is linked to the accumulation of cytotoxic amyloid beta (Aβ) and hyperphosphorylated tau protein combined with other pathological features such as synaptic loss, defective energy metabolism, imbalances in protein, and metal homeostasis. Several treatment options for AD are under investigation, including antibody-based therapy and stem ce

APA, Harvard, Vancouver, ISO, and other styles

23

Oestereich, Felix, Heiko J. Bittner, Christoph Weise, Lisa Grohmann, Lisa-Kristin Janke, Peter W. Hildebrand, Gerhard Multhaup, and Lisa-Marie Munter. "Impact of Amyloid Precursor Protein Hydrophilic Transmembrane Residues on Amyloid-Beta Generation." Biochemistry 54, no. 17 (April 23, 2015): 2777–84. http://dx.doi.org/10.1021/acs.biochem.5b00217.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Arbor, Sage. "Targeting amyloid precursor protein shuttling and processing - long before amyloid beta formation." Neural Regeneration Research 12, no. 2 (2017): 207. http://dx.doi.org/10.4103/1673-5374.200800.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Caporaso, G. L., S. E. Gandy, J. D. Buxbaum, T. V. Ramabhadran, and P. Greengard. "Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein." Proceedings of the National Academy of Sciences 89, no. 7 (April 1, 1992): 3055–59. http://dx.doi.org/10.1073/pnas.89.7.3055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Itoh, Naohiro, Masayasu Okochi, Shinji Tagami, Kouhei Nishitomi, Taisuke Nakayama, Kanta Yanagida, Akio Fukumori, et al. "Destruxin E Decreases Beta-Amyloid Generation by Reducing Colocalization of Beta-Amyloid-Cleaving Enzyme 1 and Beta-Amyloid Protein Precursor." Neurodegenerative Diseases 6, no. 5-6 (2009): 230–39. http://dx.doi.org/10.1159/000236902.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Alasmari, Fawaz, Musaad A. Alshammari, Abdullah F. Alasmari, Wael A. Alanazi, and Khalid Alhazzani. "Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism." BioMed Research International 2018 (October 25, 2018): 1–8. http://dx.doi.org/10.1155/2018/3087475.

Full text

Abstract:

Neuroinflammation has been observed in association with neurodegenerative diseases including Alzheimer’s disease (AD). In particular, a positive correlation has been documented between neuroinflammatory cytokine release and the progression of the AD, which suggests these cytokines are involved in AD pathophysiology. A histological hallmark of the AD is the presence of beta-amyloid (Aβ) plaques and tau neurofibrillary tangles. Beta-amyloid is generated by the sequential cleavage of beta (β) and gamma (γ) sites in the amyloid precursor protein (APP) by β- and γ-secretase enzymes and its accumula

APA, Harvard, Vancouver, ISO, and other styles

28

Shah, Hirak, Ashish Patel, Vruti Parikh, Afzal Nagani, Bhargav Bhimani, Umang Shah та Tushar Bambharoliya. "The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer’s Disease". CNS & Neurological Disorders - Drug Targets 19, № 3 (17 серпня 2020): 184–94. http://dx.doi.org/10.2174/1871527319666200526144141.

Full text

Abstract:

Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) is a rational target in Alzheimer’s Disease (AD) drug development due to its role in amyloidogenic cleavage of Amyloid Precursor Protein (APP) in generating Amyloid &#946; (A&#946;). This &#946;-secretase cleaves not only Amyloid Precursor Protein (APP) and its homologues, but also small series of substrates including neuregulin and &#946; subunit of voltage-gated sodium channel that play a very important role in the development and normal function of the brain. Moreover, BACE1 is modulated at the post-translational

APA, Harvard, Vancouver, ISO, and other styles

29

Godara, Amandeep, Andy Y. Wang, Knarik Arkun, Teresa Fogaren, Adnan S. Qamar, Ellen D. McPhail, James Kryzanski, Ron Riesenburger, and Raymond Comenzo. "Unraveling a rare cause of spinal stenosis: Coexistent AL and ATTR amyloidosis involving the ligamentum flavum." Surgical Neurology International 13 (January 12, 2022): 12. http://dx.doi.org/10.25259/sni_1235_2021.

Full text

Abstract:

Background: Amyloidosis is a protein misfolding disorder that leads to the deposition of beta-pleated sheets of a fibrillar derivative of various protein precursors. Identification of the type of precursor protein is integral in treatment decision-making. The presence of two different types of amyloid in the same patient is unusually rare, and there are no previous reports of two different types of amyloid deposition in the ligamentum flavum (LF) in the same patient. Case Description: Here, we describe two patients with spinal stenosis who underwent laminectomies and were found to have AL and

APA, Harvard, Vancouver, ISO, and other styles

30

De Strooper, B., and W. Annaert. "Proteolytic processing and cell biological functions of the amyloid precursor protein." Journal of Cell Science 113, no. 11 (June 1, 2000): 1857–70. http://dx.doi.org/10.1242/jcs.113.11.1857.

Full text

Abstract:

Recent research has identified some key players involved in the proteolytic processing of amyloid precursor protein (APP) to amyloid beta-peptide, the principal component of the amyloid plaques in Alzheimer patients. Interesting parallels exists with the proteolysis of other proteins involved in cell differentiation, cholesterol homeostasis and stress responses. Since the cytoplasmic domain of APP is anchored to a complex protein network that might function in axonal elongation, dendritic arborisation and neuronal cell migration, the proteolysis of APP might be critically involved in intracell

APA, Harvard, Vancouver, ISO, and other styles

31

Tienari, P. J., B. De Strooper, E. Ikonen, M. Simons, A. Weidemann, C. Czech, T. Hartmann, et al. "The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein." EMBO Journal 15, no. 19 (October 1996): 5218–29. http://dx.doi.org/10.1002/j.1460-2075.1996.tb00907.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Uhm, Kyung-Ok, Hirofumi Horike, Makoto Michikawa, and Cha-Gyun Jung. "P1-227: ATBF1 interacts with amyloid precursor protein and enhances amyloid-beta production." Alzheimer's & Dementia 6 (July 2010): S239—S240. http://dx.doi.org/10.1016/j.jalz.2010.05.778.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Selkoe, D. J. "Normal and Abnormal Biology of the beta-Amyloid Precursor Protein." Annual Review of Neuroscience 17, no. 1 (March 1994): 489–517. http://dx.doi.org/10.1146/annurev.ne.17.030194.002421.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

McMeekin, S., C. H. Williams, J. Cummings, J. Law, B. Greer, and J. A. Johnston. "A beta-site amyloid precursor protein cleaving enzyme (BACE) assay." Biochemical Society Transactions 30, no. 3 (June 1, 2002): A81. http://dx.doi.org/10.1042/bst030a081b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Narlawar, Rajeshwar, Karlheinz Baumann, Robert Schubenel, and Boris Schmidt. "Curcumin Derivatives Inhibit or Modulate Beta-Amyloid Precursor Protein Metabolism." Neurodegenerative Diseases 4, no. 2-3 (2007): 88–93. http://dx.doi.org/10.1159/000101832.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Zhong, Z., J. Higaki, K. Murakami, Y. Wang, R. Catalano, D. Quon, and B. Cordell. "Secretion of beta-amyloid precursor protein involves multiple cleavage sites." Journal of Biological Chemistry 269, no. 1 (January 1994): 627–32. http://dx.doi.org/10.1016/s0021-9258(17)42395-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Davies, T. A., H. J. Long, K. Sgro, W. H. Rathbun, M. E. McMenamin, K. Seetoo, H. Tibbles, et al. "Activated Alzheimer Disease Platelets Retain More Beta Amyloid Precursor Protein." Neurobiology of Aging 18, no. 2 (March 1997): 147–53. http://dx.doi.org/10.1016/s0197-4580(97)00013-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Okuda, R., K. Uchida, S. Tateyama, R. Yamaguchi, H. Nakayama, and N. Goto. "The distribution of amyloid beta precursor protein in canine brain." Acta Neuropathologica 87, no. 2 (February 1994): 161–67. http://dx.doi.org/10.1007/bf00296186.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Xu, Huaxi. "Cellular and molecular basis of beta-amyloid precursor protein metabolism." Frontiers in Bioscience 3, no. 4 (1998): d399–407. http://dx.doi.org/10.2741/a283.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Farber, SA, RM Nitsch, JG Schulz, and RJ Wurtman. "Regulated secretion of beta-amyloid precursor protein in rat brain." Journal of Neuroscience 15, no. 11 (November 1, 1995): 7442–51. http://dx.doi.org/10.1523/jneurosci.15-11-07442.1995.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Reichard, R. Ross, Charles L. White, Christa L. Hladik, and David Dolinak. "Beta-Amyloid Precursor Protein Staining in Nonhomicidal Pediatric Medicolegal Autopsies." Journal of Neuropathology & Experimental Neurology 62, no. 3 (March 2003): 237–47. http://dx.doi.org/10.1093/jnen/62.3.237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Cunningham, D. D. "Protease nexin-2/amyloid beta-protein precursor: a cerebral anticoagulant?" Journal of Clinical Investigation 92, no. 5 (November 1, 1993): 2090. http://dx.doi.org/10.1172/jci116807.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Sisodia, S. S. "Beta-amyloid precursor protein cleavage by a membrane-bound protease." Proceedings of the National Academy of Sciences 89, no. 13 (July 1, 1992): 6075–79. http://dx.doi.org/10.1073/pnas.89.13.6075.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Yoshikai, Shun-ichi, Hiroyuki Sasaki, Katsumi Doh-ura, Hirokazu Furuya, and Yoshiyuki Sakaki. "Genomic organization of the human amyloid beta-protein precursor gene." Gene 87, no. 2 (March 1990): 257–63. http://dx.doi.org/10.1016/0378-1119(90)90310-n.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Yoshikai, Shun-ichi, Hiroyuki Sasaki, Katsumi Doh-ura, Hirokazu Furuya, and Yoshiyuki Sakaki. "Genomic organization of the human-amyloid beta-protein precursor gene." Gene 102, no. 2 (June 1991): 291–92. http://dx.doi.org/10.1016/0378-1119(91)90093-q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ishiura, Shoichi, Kazuhiko Tagawa, Kei Maruyama, and Koichi Suzuki. "Proteolytic cleavage of the Alzheimer's disease amyloid beta precursor protein." Neuroscience Research Supplements 17 (January 1992): 19. http://dx.doi.org/10.1016/0921-8696(92)90671-m.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Altstiel, Larry D., and Nikolaos K. Robakis. "Expression of beta-amyloid precursor protein on neuron plasma membranes." Biological Psychiatry 25, no. 7 (April 1989): A118—A119. http://dx.doi.org/10.1016/0006-3223(89)91725-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Okuda, R., K. Uchida, S. Tateyama, R. Yamaguchi, H. Nakayama, and N. Goto. "The distribution of amyloid beta precursor protein in canine brain." Acta Neuropathologica 87, no. 2 (February 1, 1994): 161–67. http://dx.doi.org/10.1007/s004010050071.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Van Nostrand, W., A. Schmaier, J. Farrow, and D. Cunningham. "Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein." Science 248, no. 4956 (May 11, 1990): 745–48. http://dx.doi.org/10.1126/science.2110384.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Schubert, D., R. Schroeder, M. LaCorbiere, T. Saitoh, and G. Cole. "Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein." Science 241, no. 4862 (July 8, 1988): 223–26. http://dx.doi.org/10.1126/science.2968652.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!